Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.

Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE.

Neurooncol Pract. 2019 Sep;6(5):364-374. doi: 10.1093/nop/npz017. Epub 2019 Apr 12.

PMID:
31555451
2.

Re-irradiation for malignant glioma: Toward patient selection and defining treatment parameters for salvage.

Shen CJ, Kummerlowe MN, Redmond KJ, Martinez-Gutierrez JC, Usama SM, Holdhoff M, Grossman SA, Laterra JJ, Strowd RE, Kleinberg LR.

Adv Radiat Oncol. 2018 Jul 10;3(4):582-590. doi: 10.1016/j.adro.2018.06.005. eCollection 2018 Oct-Dec.

3.

Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.

Schernberg A, Dhermain F, Ammari S, Dumont SN, Domont J, Patrikidou A, Pallud J, Dezamis É, Deutsch É, Louvel G.

Cancer Radiother. 2018 Feb;22(1):9-16. doi: 10.1016/j.canrad.2017.06.013. Epub 2017 Dec 6.

PMID:
29217134
4.

Radiosurgery reirradiation for high-grade glioma recurrence: a retrospective analysis.

Pinzi V, Orsi C, Marchetti M, Milanesi IM, Bianchi LC, DiMeco F, Cuccarini V, Farinotti M, Ferroli P, Finocchiaro G, Franzini A, Fumagalli M, Silvani A, Fariselli L.

Neurol Sci. 2015 Aug;36(8):1431-40. doi: 10.1007/s10072-015-2172-7. Epub 2015 Mar 25.

PMID:
25805705
5.

Subventricular zone involvement at recurrence is a strong predictive factor of outcome following high grade glioma reirradiation.

Attal J, Chaltiel L, Lubrano V, Sol JC, Lanaspeze C, Vieillevigne L, Latorzeff I, Cohen-Jonathan Moyal E.

J Neurooncol. 2018 Jan;136(2):413-419. doi: 10.1007/s11060-017-2669-4. Epub 2017 Dec 22.

PMID:
29273890
6.

Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.

Lin AJ, Hui C, Dahiya S, Lu HC, Kim AH, Campian JL, Tsien C, Zipfel GJ, Rich KM, Chicoine M, Huang J.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):194-203. doi: 10.1016/j.ijrobp.2018.05.011. Epub 2018 Jun 30.

PMID:
29970312
7.

Modern reirradiation for recurrent gliomas can safely delay tumor progression.

Youland RS, Lee JY, Kreofsky CR, Brown PD, Uhm JH, Laack NN.

Neurooncol Pract. 2018 Mar;5(1):46-55. doi: 10.1093/nop/npx014. Epub 2017 Jun 15.

8.

Hypofractionated Stereotactic Radiotherapy as a Salvage Therapy for Recurrent High-Grade Gliomas: Single-Center Experience.

Reynaud T, Bertaut A, Farah W, Thibouw D, Crehange G, Truc G, Vulquin N.

Technol Cancer Res Treat. 2018 Jan 1;17:1533033818806498. doi: 10.1177/1533033818806498.

9.

Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival.

Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, Ryu S.

J Neurooncol. 2009 Apr;92(2):185-91. doi: 10.1007/s11060-008-9752-9. Epub 2008 Dec 9.

PMID:
19066727
10.

Stereotactic radiosurgery (SRS) in high-grade glioma: judicious selection of small target volumes improves results.

Bokstein F, Blumenthal DT, Corn BW, Gez E, Matceyevsky D, Shtraus N, Ram Z, Kanner AA.

J Neurooncol. 2016 Feb;126(3):551-7. doi: 10.1007/s11060-015-1997-5. Epub 2015 Nov 24.

PMID:
26603164
11.

Reirradiation as part of a salvage treatment approach for progressive non-pontine pediatric high-grade gliomas: preliminary experiences from the German HIT-HGG study group.

Müller K, Scheithauer H, Pietschmann S, Hoffmann M, Rössler J, Graf N, Baumert BG, Christiansen H, Kortmann RD, Kramm CM, von Bueren AO.

Radiat Oncol. 2014 Aug 12;9:177. doi: 10.1186/1748-717X-9-177.

12.

Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

Niranjan A, Kano H, Iyer A, Kondziolka D, Flickinger JC, Lunsford LD.

J Neurosurg. 2015 Apr;122(4):757-65. doi: 10.3171/2014.11.JNS13295. Epub 2015 Jan 16.

PMID:
25594327
13.

Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors.

Buglione M, Maddalo M, Mazzeo E, Bonomo P, Spiazzi L, Bruni A, Paiar F, Triggiani L, Greto D, Rubino L, Livi L, Bertoni F, Magrini SM.

Tumori. 2015 Sep-Oct;101(5):585-92. doi: 10.5301/tj.5000368. Epub 2015 Jun 15.

PMID:
26108237
14.

Salvage radiosurgery for selected patients with recurrent malignant gliomas.

Martínez-Carrillo M, Tovar-Martín I, Zurita-Herrera M, Del Moral-Ávila R, Guerrero-Tejada R, Saura-Rojas E, Osorio-Ceballos JL, Arrebola-Moreno JP, Expósito-Hernández J.

Biomed Res Int. 2014;2014:657953. doi: 10.1155/2014/657953. Epub 2014 May 7.

15.

Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.

Scholtyssek F, Zwiener I, Schlamann A, Seidel C, Meixensberger J, Bauer M, Hoffmann KT, Combs SE, von Bueren AO, Kortmann RD, Müller K.

Radiat Oncol. 2013 Jul 3;8:161. doi: 10.1186/1748-717X-8-161.

16.

Spinal cord stimulation as adjuvant during chemotherapy and reirradiation treatment of recurrent high-grade gliomas.

Clavo B, Robaina F, Jorge IJ, Cabrera R, Ruiz-Egea E, Szolna A, Otermin E, Llontop P, Carames MA, Santana-Rodríguez N, Sminia P.

Integr Cancer Ther. 2014 Nov;13(6):513-9. doi: 10.1177/1534735414550037. Epub 2014 Sep 15.

PMID:
25228535
17.

Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes.

McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):819-27. doi: 10.1016/j.ijrobp.2014.07.030. Epub 2014 Sep 11.

PMID:
25220718
18.

Large volume reirradiation as salvage therapy for glioblastoma after progression on bevacizumab.

Magnuson W, Ian Robins H, Mohindra P, Howard S.

J Neurooncol. 2014 Mar;117(1):133-9. doi: 10.1007/s11060-014-1363-z. Epub 2014 Jan 28.

PMID:
24469853
19.

Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France).

Lévy S, Chapet S, Scher N, Debbi K, Ruffier A, Bernadou G, Pointreau Y, Calais G.

Cancer Radiother. 2017 Dec;21(8):759-765. doi: 10.1016/j.canrad.2017.05.006. Epub 2017 Nov 8.

PMID:
29128197
20.

Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM).

Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D.

Cancer. 2005 Nov 15;104(10):2168-73.

Supplemental Content

Support Center